BioCryst Pharmaceuticals Management
Management criteria checks 3/4
BioCryst Pharmaceuticals' CEO is Jon Stonehouse, appointed in Jan 2007, has a tenure of 17.67 years. total yearly compensation is $4.78M, comprised of 13.9% salary and 86.1% bonuses, including company stock and options. directly owns 0.43% of the company’s shares, worth MX$132.59M. The average tenure of the management team and the board of directors is 4.5 years and 5.1 years respectively.
Key information
Jon Stonehouse
Chief executive officer
US$4.8m
Total compensation
| CEO salary percentage | 13.9% |
| CEO tenure | 17.7yrs |
| CEO ownership | 0.4% |
| Management average tenure | 4.5yrs |
| Board average tenure | 5.1yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$146m |
| Mar 31 2024 | n/a | n/a | -US$209m |
| Dec 31 2023 | US$5m | US$666k | -US$227m |
| Sep 30 2023 | n/a | n/a | -US$236m |
| Jun 30 2023 | n/a | n/a | -US$243m |
| Mar 31 2023 | n/a | n/a | -US$226m |
| Dec 31 2022 | US$7m | US$640k | -US$247m |
| Sep 30 2022 | n/a | n/a | -US$193m |
| Jun 30 2022 | n/a | n/a | -US$210m |
| Mar 31 2022 | n/a | n/a | -US$194m |
| Dec 31 2021 | US$7m | US$583k | -US$184m |
| Sep 30 2021 | n/a | n/a | -US$227m |
| Jun 30 2021 | n/a | n/a | -US$214m |
| Mar 31 2021 | n/a | n/a | -US$209m |
| Dec 31 2020 | US$6m | US$567k | -US$183m |
| Sep 30 2020 | n/a | n/a | -US$125m |
| Jun 30 2020 | n/a | n/a | -US$116m |
| Mar 31 2020 | n/a | n/a | -US$115m |
| Dec 31 2019 | US$2m | US$550k | -US$109m |
| Sep 30 2019 | n/a | n/a | -US$134m |
| Jun 30 2019 | n/a | n/a | -US$126m |
| Mar 31 2019 | n/a | n/a | -US$107m |
| Dec 31 2018 | US$4m | US$550k | -US$101m |
| Sep 30 2018 | n/a | n/a | -US$93m |
| Jun 30 2018 | n/a | n/a | -US$79m |
| Mar 31 2018 | n/a | n/a | -US$77m |
| Dec 31 2017 | US$4m | US$533k | -US$66m |
Compensation vs Market: Jon's total compensation ($USD4.78M) is above average for companies of similar size in the MX market ($USD907.35K).
Compensation vs Earnings: Jon's compensation has been consistent with company performance over the past year.
CEO
Jon Stonehouse (63 yo)
17.7yrs
Tenure
US$4,777,778
Compensation
Mr. Jon P. Stonehouse has been the Chief Executive Officer and Executive Director of BioCryst Pharmaceuticals, Inc. at Shionogi & Co. Ltd. since joining in January 8, 2007 and also has been its President s...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Executive Director | 17.7yrs | US$4.78m | 0.43% $ 132.6m | |
| Senior VP | 4.4yrs | US$1.79m | 0.082% $ 25.5m | |
| Senior VP | 18yrs | US$1.93m | 0.089% $ 27.6m | |
| Chief Research & Development Officer | 3.5yrs | US$2.39m | 0.055% $ 17.0m | |
| Senior VP & Chief Commercial Officer | 4.7yrs | US$1.74m | 0.10% $ 31.2m | |
| Chief Communications Officer | no data | no data | no data | |
| Chief People Officer | no data | no data | no data | |
| Chief Development Officer | 16.2yrs | US$2.66m | 0% $ 0 | |
| Chief Discovery Officer | 10.9yrs | US$2.57m | 0% $ 0 | |
| Chief Data & Insights Officer | 2.8yrs | no data | no data | |
| Chief Strategy Officer | 2yrs | no data | no data | |
| Chief Business Development Officer | 1.7yrs | no data | no data |
4.5yrs
Average Tenure
57yo
Average Age
Experienced Management: BCRX *'s management team is considered experienced (4.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Executive Director | 17.7yrs | US$4.78m | 0.43% $ 132.6m | |
| Independent Director | 3.2yrs | US$434.82k | 0.033% $ 10.3m | |
| Independent Director | 5.7yrs | US$446.90k | 0.024% $ 7.4m | |
| Independent Director | 4.6yrs | US$434.54k | 0.014% $ 4.2m | |
| Independent Director | 12.9yrs | US$432.74k | 0.0062% $ 1.9m | |
| Independent Director | 5.8yrs | US$433.57k | 0.022% $ 6.9m | |
| Independent Chair | 12.7yrs | US$470.30k | 0.034% $ 10.5m | |
| Independent Director | 3yrs | US$424.40k | 0.017% $ 5.2m | |
| Independent Director | 2.6yrs | US$423.15k | 0.010% $ 3.1m | |
| Independent Director | 3yrs | US$422.32k | 0.010% $ 3.2m |
5.1yrs
Average Tenure
63.5yo
Average Age
Experienced Board: BCRX *'s board of directors are considered experienced (5.1 years average tenure).